Alterity Therapeutics Limited (PBN) — Financial Flexibility Index
Alterity Therapeutics Limited (PBN) has a Financial Flexibility Index of -1.12x as of June 2023. Free cash flow of €-5.05 Million (operating CF €-5.06 Million minus capex €1.22K) represents -1% of total liabilities (€4.50 Million). Check PBN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alterity Therapeutics Limited Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Alterity Therapeutics Limited across 12 annual periods. See PBN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Alterity Therapeutics Limited (2014–2025)
Year-by-year free cash flow to debt coverage for Alterity Therapeutics Limited. For the full company profile including market capitalisation, see PBN market cap overview.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.16x | €-11.45 Million | €-11.45 Million | €3.62 Million | ▼ -36.1% |
| 2024 | -2.32x | €-12.60 Million | €-12.61 Million | €5.43 Million | ▲ +47.8% |
| 2023 | -4.45x | €-20.03 Million | €-20.04 Million | €4.50 Million | ▼ -114.0% |
| 2022 | -2.08x | €-12.25 Million | €-12.34 Million | €5.89 Million | ▲ +62.6% |
| 2021 | -5.56x | €-17.32 Million | €-17.33 Million | €3.12 Million | ▼ -62.8% |
| 2020 | -3.41x | €-9.41 Million | €-9.43 Million | €2.76 Million | ▲ +17.9% |
| 2019 | -4.16x | €-13.95 Million | €-13.95 Million | €3.36 Million | ▼ -77.8% |
| 2018 | -2.34x | €-6.18 Million | €-6.25 Million | €2.64 Million | ▲ +36.3% |
| 2017 | -3.67x | €-5.84 Million | €-5.87 Million | €1.59 Million | ▼ -16.6% |
| 2016 | -3.15x | €-7.42 Million | €-7.42 Million | €2.36 Million | ▲ +21.1% |
| 2015 | -3.98x | €-10.84 Million | €-10.87 Million | €2.72 Million | ▼ -16.6% |
| 2014 | -3.42x | €-13.51 Million | €-13.54 Million | €3.95 Million | — |